Tumor lysis syndrome early after treatment with bortezomib for multiple myeloma

Pharmacotherapy. 2006 Aug;26(8):1205-6; discussion 1206. doi: 10.1592/phco.26.8.1205.
No abstract available

Publication types

  • Comment

MeSH terms

  • Adult
  • Aged
  • Boronic Acids / adverse effects*
  • Bortezomib
  • Female
  • Humans
  • Male
  • Middle Aged
  • Multiple Myeloma / drug therapy*
  • Protease Inhibitors / adverse effects*
  • Pyrazines / adverse effects*
  • Tumor Lysis Syndrome / etiology*

Substances

  • Boronic Acids
  • Protease Inhibitors
  • Pyrazines
  • Bortezomib